Abstract
The pancreas can be involved secondarily by extrapancreatic neoplasms, either by direct invasion or by metastatic spread along lymphatic channels, perineural clefts, or the blood stream. In principle, the possibility of a secondary neoplasm should always be considered as a differential when diagnosing a pancreatic cancer. This chapter focuses on the more common malignant neoplasms that metastasize to the pancreas, and provides detailed information on the differential diagnosis, including a table with useful immunohistochemical markers. The rare occurrence in patients with BRCA-germline mutations of synchronous primary ductal adenocarcinoma of the pancreas and metastasis from ovarian cancer is discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Crippa S, Angelini C, Mussi C, Bonardi C, Romano F, Sartori P, Uggeri F, Bovo G. Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg. 2006;30:1536–42.
Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng JD. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444:527–35.
Stelow EB, Yaziji H. Immunohistochemistry, carcinomas of unknown primary, and incidence rates. Semin Diagn Pathol. 2018;35:143–52.
Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med. 2011;135:92–109.
Park S-Y, Kim B-H, Kim J-H, Lee S, Kang GH. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med. 2007;131:1561–7.
Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766–72.
Cai YC, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol. 2001;32:1087–93.
Ordonez NG. Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol. 2003;27:1418–28.
Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin. An immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303–10.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Campbell, F., Verbeke, C.S. (2021). Secondary Neoplasia. In: Pathology of the Pancreas. Springer, Cham. https://doi.org/10.1007/978-3-030-49848-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-49848-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-49847-4
Online ISBN: 978-3-030-49848-1
eBook Packages: MedicineMedicine (R0)